Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Khiron Life Sciences Corp...

    PNK: KHRNF · Real-Time Price · USD
    0.00
    -0.00 (-100.00%)
    At close: Jun 05, 2025, 11:48 AM

    Khiron Life Sciences Statistics

    Share Statistics

    Khiron Life Sciences has 5,228.2B shares outstanding. The number of shares has increased by 644832.17% in one year.

    Shares Outstanding

    n/a
    		 5,228.2B

    Shares Change (YoY)

    n/a
    		 644832.17%

    Shares Change (QoQ)

    n/a
    		 0.26%

    Owned by Institutions (%)

    n/a
    		 n/a

    Shares Floating

    n/a
    		 n/a

    Failed to Deliver (FTD) Shares

    n/a
    		 n/a

    FTD / Avg. Volume

    n/a
    		 n/a

    Short Selling Information

    The latest short interest is 43.74K, so 0% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 43.74K

    Short % of Shares Out

    n/a
    		 n/a

    Short % of Float

    n/a
    		 n/a

    Short Ratio (days to cover)

    n/a
    		 103.15

    Valuation Ratios

    The PE ratio is -1.04 and the forward PE ratio is 0.11. Khiron Life Sciences's PEG ratio is 0.

    PE Ratio

    n/a
    		 -1.04

    Forward PE

    n/a
    		 0.11

    PS Ratio

    n/a
    		 2.7

    Forward PS

    n/a
    		 n/a

    PB Ratio

    n/a
    		 1.04

    P/FCF Ratio

    n/a
    		 -1.56

    PEG Ratio

    n/a
    		 0
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for Khiron Life Sciences.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 3.08, with a Debt / Equity ratio of 0.07.

    Current Ratio

    n/a
    		 3.08

    Quick Ratio

    n/a
    		 1.86

    Debt / Equity

    n/a
    		 0.07

    Debt / EBITDA

    n/a
    		 -0.07

    Debt / FCF

    n/a
    		 -0.1

    Interest Coverage

    n/a
    		 -44.47

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 $41,274.19

    Profits Per Employee

    n/a
    		 $-106,867.74

    Employee Count

    n/a
    		 310

    Asset Turnover

    n/a
    		 0.3

    Inventory Turnover

    n/a
    		 0.68

    Taxes

    Income Tax

    n/a
    		 -465K

    Effective Tax Rate

    n/a
    		 1.38%

    Stock Price Statistics

    The stock price has increased by null% in the last 52 weeks. The beta is 4.63, so Khiron Life Sciences's price volatility has been higher than the market average.

    Beta

    n/a
    		 4.63

    52-Week Price Change

    n/a
    		 n/a

    50-Day Moving Average

    n/a
    		 0

    200-Day Moving Average

    n/a
    		 0

    Relative Strength Index (RSI)

    n/a
    		 51.49

    Average Volume (20 Days)

    n/a
    		 n/a

    Income Statement

    In the last 12 months, Khiron Life Sciences had revenue of 12.79M and earned -33.13M in profits. Earnings per share was -0.2.

    Revenue

    n/a
    		 12.79M

    Gross Profit

    n/a
    		 6.37M

    Operating Income

    n/a
    		 -19.79M

    Net Income

    n/a
    		 -33.13M

    EBITDA

    n/a
    		 -32.03M

    EBIT

    n/a
    		 -33.15M

    Earnings Per Share (EPS)

    n/a
    		 -0.2
    Full Income Statement

    Balance Sheet

    The company has 8.92M in cash and 2.23M in debt, giving a net cash position of 6.7M.

    Cash & Cash Equivalents

    n/a
    		 8.92M

    Total Debt

    n/a
    		 2.23M

    Net Cash

    n/a
    		 6.7M

    Retained Earnings

    n/a
    		 -116.81M

    Total Assets

    n/a
    		 38.45M

    Working Capital

    n/a
    		 8.72M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -20.4M and capital expenditures -1.74M, giving a free cash flow of -22.14M.

    Operating Cash Flow

    n/a
    		 -20.4M

    Capital Expenditures

    n/a
    		 -1.74M

    Free Cash Flow

    n/a
    		 -22.14M

    FCF Per Share

    n/a
    		 -0.13
    Full Cash Flow Statement

    Margins

    Gross margin is 49.79%, with operating and profit margins of -154.65% and -258.92%.

    Gross Margin

    n/a
    		 49.79%

    Operating Margin

    n/a
    		 -154.65%

    Pretax Margin

    n/a
    		 -262.56%

    Profit Margin

    n/a
    		 -258.92%

    EBITDA Margin

    n/a
    		 -250.36%

    EBIT Margin

    n/a
    		 -154.65%

    FCF Margin

    n/a
    		 -173.07%

    Dividends & Yields

    KHRNF does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    Currently there are no analyst rating for KHRNF.

    Price Target

    n/a
    		 n/a

    Price Target Difference

    n/a
    		 n/a

    Analyst Consensus

    n/a
    		 n/a

    Analyst Count

    n/a
    		 n/a
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Scores

    Altman Z-Score

    n/a
    		 2191.52

    Piotroski F-Score

    n/a
    		 2

    Add to Watchlist